Overview

DPT Laboratories, Ltd. is a contract development and manufacturing organization specializing in semi-solid and liquid dosage forms. The company offers comprehensive services from pharmaceutical development to commercial manufacturing. As a subsidiary of the CMIC Group, DPT serves clients across various therapeutic areas, leveraging decades of industry expertise.

Therapeutic areas

API / Drug Master Files

DPT Laboratories, Ltd. holds 40 active (58 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • BRIVARACETAMActive2025-03-31
  • LOSARTAN POTASSIUM USPActive2024-09-26
  • RIVAROXABAN USPActive2024-09-19
  • IRBESARTAN USPActive2023-11-07
  • TICAGRELORActive2022-01-27
  • BSPG CANNABIDIOL (CBD) APIActive2021-05-13
  • ORLISTATActive2021-04-30
  • LACOSAMIDEActive2021-03-09
  • VIGABATRIN USPActive2017-07-29
  • PREGABALIN (ALTERNATIVE PROCESS)Active2016-08-01
  • LEVETIRACETAM (PROCESS B)Active2016-01-08
  • MESALAMINE USPActive2015-11-06
  • OLMESARTAN MEDOXOMIL USPActive2014-01-28
  • VALSARTAN USPActive2011-03-29
  • TRITYL LOSARTANActive2010-09-15

Showing 15 of 58 Drug Master Files.

FDA compliance signals

15 FDA enforcement records linked to this company.

  • 4832026-02-10

    Control procedures to monitor and validate performance

  • 4832026-02-10

    Absence of Written Procedures

  • 4832018-12-14

    Authority lacking to review records, investigate errors

  • 4832018-12-14

    Written records kept in individual logs

  • 4832018-12-14

    Identification of Equipment and Lines

  • 4832016-08-26

    Cleaning / Sanitizing / Maintenance

  • 4832016-08-26

    SOPs not followed / documented

  • 4832016-08-26

    Procedures to be written and followed

  • 4832014-04-25

    Label storage access limited to authorized personnel

  • 4832014-04-25

    Written procedures not followed

  • 4832014-04-25

    Complete test data included in records

  • 4832014-04-25

    Protective Apparel Not Worn

  • 4832014-04-25

    No written record of investigation

  • 4832014-04-25

    Scientifically sound laboratory controls

  • 4832014-04-25

    Written procedures describing in detail

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.